Adis will reveal a brand new look for its regulatory literature monitoring solution at the DIA Annual Meeting, taking place from June 26th to 30th in Philadelphia, USA.
For more than a decade, Adis has provided customized literature monitoring services to pharmacovigilance departments under the name of Reactions Pharmacovigilance Service. The outsourcing solutions offered include ICSR monitoring, local literature monitoring and annual reports. The service will be renamed as Adis Pharmacovigilance as part of the current rebranding initiative.
To celebrate the re-launch at DIA, a champagne reception will be held at the Springer Nature stand on the evening of Monday 27th June, immediately after the official conference opening ceremony. The event will be attended by Springer Nature colleagues including Director of Product Management for Adis Business Intelligence, Mirko Walter, and Product Manager for Pharmacovigilance, Suzanne Berresford, who will be on hand to speak to delegates about their literature monitoring needs.
“The Adis reactions portfolio has a very proud heritage and an enviable position as the industry leader in delivering pharmacovigilance content and solutions. The bold new branding reflects our ambitions in this area, in which we plan to continue growing and offering cutting edge, expert solutions for our customers.”
Adis is the industry leader with more than 30 years’ experience of delivering pharmacovigilance content and solutions to over 6,000 customers globally. Adis is a publishing imprint of Springer Nature, a scientific publishing company resulting from the May 2015 merger of Springer Science+Business Media and Georg von Holtzbrinck Publishing Group’s Nature Publishing Group, Palgrave Macmillan, and Macmillan Education.
Further information about Adis Pharmacovigilance can be found here.